ArticleScientific reports2026
Comparative spectral analysis of blood and saliva in breast cancer, benign breast disease and healthy controls using ATR-FTIR.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Breast cancer (BC) ranks among the most prevalent tumors affecting women. This research explores the ability of Attenuated Total Reflection Infrared Spectroscopy (ATR-FTIR) to identify different biochemical elements found in bodily fluids such as serum and saliva from individuals with BC, individuals with benign breast disease (BBD), and healthy individuals. A cross-sectional analysis was performed on samples from 73 participants, comprising 31 with BC, 18 with BBD, and 24 healthy subjects, to examine biochemical differences across the groups. The findings indicated that the levels of the biochemical elements nucleic acids, proteins, lipids and glycogen significantly differed among the fluids. Specifically, the wavenumber of 2930 cm− 1 in saliva was capable of statistically differentiating BC patients from BBD patients and healthy controls. In the serum samples, a significant difference was observed at 1295 cm− 1 (p = 0.0014). However, serum collection has some disadvantages such as invasiveness and the need for trained personnel. Wavenumbers in saliva have emerged as potential breast cancer biomarkers, suggesting that this approach could serve as a valuable, noninvasive method and readily available option for breast cancer screening. ATR-FTIR spectroscopy has the potential to pave the way for the investigation of more efficient and less invasive clinical diagnostic methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.